Last reviewed · How we verify

NCT04294108

Why in Hospital After VATS Lobectomy

Completed Last updated 3 November 2021
What this trial tests

trial testing Prolong in-hospital stay in Carcinoma, Non-Small-Cell Lung in 160 participants. Completed in 18 September 2021.

Timeline
20 April 2020
Primary endpoint
18 December 2020
18 September 2021

Quick facts

Lead sponsorRigshospitalet, Denmark
StatusCompleted
Study typeOBSERVATIONAL
Enrollment160
Start date20 April 2020
Primary completion18 December 2020
Estimated completion18 September 2021
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Rigshospitalet, Denmark

Who can join

18 and older, any sex, with Carcinoma, Non-Small-Cell Lung or Pain, Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to identify specific or potential reasons that prolong the length of hospital stay after video-assisted thoracoscopic surgery lobectomy. The hypothesis is that patients who are still in hospital after video-assisted thoracoscopic surgery lobectomy are associated with prolonged air leak, infection, pneumonia, atrial fibrillation or other complications or social factors.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Reasons for staying in hospital after video-assisted thoracoscopic surgery lobectomy.
    Huang L, Kehlet H, Petersen RH. · · 2022 · cited 43× · PMID 35511502 · DOI 10.1093/bjsopen/zrac050

Verify or expand the search:

Other recruiting trials for Carcinoma, Non-Small-Cell Lung

Currently open trials in the same condition.

Other Rigshospitalet, Denmark trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04294108.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing